Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-131311
Filing Date
2018-04-25
Accepted
2018-04-25 16:10:03
Documents
1
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d573835ddefa14a.htm DEFA14A 43023
  Complete submission text file 0001193125-18-131311.txt   44098
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 18774442
SIC: 2836 Biological Products, (No Diagnostic Substances)